
Aeren Pharma Foils Private Limited
Manufactures and distributes aluminum and metal products, including foils, packaging materials, and plastic bottles.
Manufactures and distributes aluminum and metal products, including foils, packaging materials, and plastic bottles.
Aeren Pharma Foils Private Limited (APFPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 August 2021 (Three years and seven months 18 days old ). Its registered office is in Jammu, Jammu & Kashmir, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹92.93 Cr.
Amrish Aggarwal, Goldie Agarwal, Dhruv Aggarwal, and One other member serve as directors at the Company.
Jammu, Jammu & Kashmir, India
+91-XXXXXXXXXX
U28999JK2021PTC012613
012613
Private Limited Indian Non-Government Company
11 Aug 2021
30 Sep 2023
31 Mar 2023
Unlisted
Roc Jammu
Name | Designation | Appointment Date | Status |
---|---|---|---|
Amrish Aggarwal ![]() | Director | 11-Aug-2021 | Current |
Goldie Agarwal ![]() | Director | 11-Aug-2021 | Current |
Dhruv Aggarwal | Additional Director | 03-Sep-2024 | Current |
Kriti Aggarwal | Additional Director | 03-Sep-2024 | Current |
Aeren Pharma Foils Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Aeren Pharma Foils's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Amrish Aggarwal, Goldie Agarwal and 2 more are mutual person
Amrish Aggarwal and Goldie Agarwal are mutual person
Amrish Aggarwal is a mutual person
Amrish Aggarwal and Goldie Agarwal are mutual person
Amrish Aggarwal, Goldie Agarwal and 2 more are mutual person
Amrish Aggarwal, Goldie Agarwal and 2 more are mutual person
₹929.34 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
27 May 2024 | Standard Chartered Bank | ₹11.00 Cr | Open |
27 May 2024 | Standard Chartered Bank | ₹1.26 Cr | Open |
14 Jun 2023 | Others | ₹22.40 Cr | Open |
23 May 2023 | Others | ₹15.50 Cr | Open |
24 Feb 2023 | Standard Chartered Bank | ₹1.78 Cr | Open |
Aeren Pharma Foils has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aeren Pharma Foils, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aeren Pharma Foils's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dhruv Aggarwal was appointed as a Additional Director was appointed as a Additional Director on 03 Sep 2024 & has been associated with this company since 6 months 26 days .
Kriti Aggarwal was appointed as a Additional Director was appointed as a Additional Director on 03 Sep 2024 & has been associated with this company since 6 months 26 days .
A charge with Standard Chartered Bank amounted to Rs. 110.00 M with Charge ID 100927419 was registered on 27 May 2024.
A charge with Standard Chartered Bank amounted to Rs. 12.59 M with Charge ID 100927424 was registered on 27 May 2024.
A charge with Standard Chartered Bank of Rs. 165.00 M registered on 24 Feb 2023 with Charge ID 100704026 was modified on 27 May 2024.
A charge with Others of Rs. 224.00 M registered on 14 Jun 2023 with Charge ID 100750493 was modified on 22 Dec 2023.
Aeren Pharma Foils Private Limited was incorporated on 11 Aug 2021.
The authorized share capital of Aeren Pharma Foils Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.
Currently 4 directors are associated with Aeren Pharma Foils Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Aeren Pharma Foils Private Limited is 28 A/B Gandhi Nagar Kashmir India, Jammu, Jammu & Kashmir, 180004.
The corporate identification number (CIN) of Aeren Pharma Foils Private Limited is U28999JK2021PTC012613 and the company number is 012613 as per Ministry of Corporate Affairs (MCA).
As per the financial statements for fiscal Year 2023, The total open charges for Aeren Pharma Foils Private Limited amount to ₹ 92.93 Cr.
The most recent Balance Sheet for Aeren Pharma Foils Private Limited was filed with the ROC on 31 Mar 2023.